BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8303650)

  • 1. Aggregation of human and canine platelets: modulation by purine nucleotides.
    Soslau G; Arabe L; Parker J; Pelleg A
    Thromb Res; 1993 Oct; 72(2):127-37. PubMed ID: 8303650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular ATP inhibits agonist-induced mobilization of internal calcium in human platelets.
    Soslau G; McKenzie RJ; Brodsky I; Devlin TM
    Biochim Biophys Acta; 1995 Jul; 1268(1):73-80. PubMed ID: 7626665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.
    Greenberg SS; Johns A; Kleha J; Xie J; Wang Y; Bianchi J; Conley K
    J Pharmacol Exp Ther; 1994 Mar; 268(3):1352-61. PubMed ID: 8138950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A possible dual physiological role of extracellular ATP in the modulation of platelet aggregation.
    Soslau G; Youngprapakorn D
    Biochim Biophys Acta; 1997 Feb; 1355(2):131-40. PubMed ID: 9042333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occupancy of P2 purinoceptors with unique properties modulates the function of human platelets.
    Soslau G; Brodsky I; Parker J
    Biochim Biophys Acta; 1993 Jun; 1177(2):199-207. PubMed ID: 7684612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the P2-purinoceptor antagonist, suramin, on human platelet aggregation induced by adenosine 5'-diphosphate.
    Hourani SM; Hall DA; Nieman CJ
    Br J Pharmacol; 1992 Feb; 105(2):453-7. PubMed ID: 1559134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithrombotic effects of peroxynitrite: inhibition and reversal of aggregation in human platelets.
    Yin K; Lai PS; Rodriguez A; Spur BW; Wong PY
    Prostaglandins; 1995 Sep; 50(3):169-78. PubMed ID: 8750213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined administration of 5-HT2 and thromboxane A2 antagonists: effects on platelet aggregation and isolated cardiac muscle.
    Shaw LA; Batey AJ; Coker SJ
    Br J Pharmacol; 1997 Jul; 121(5):875-82. PubMed ID: 9222543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
    Yin K; Halushka PV; Yan YT; Wong PY
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.
    Ohkubo S; Nakahata N; Ohizumi Y
    Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanism of thromboxane A(2)-induced platelet aggregation. Essential role for p2t(ac) and alpha(2a) receptors.
    Paul BZ; Jin J; Kunapuli SP
    J Biol Chem; 1999 Oct; 274(41):29108-14. PubMed ID: 10506165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of ADP-induced platelet activation by 7-chloro-4-nitrobenz-2-oxa-1,3-diazole: covalent modification of aggregin, a putative ADP receptor.
    Puri RN; Colman RW
    J Cell Biochem; 1996 Apr; 61(1):97-108. PubMed ID: 8726359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An inhibitor of collagen-induced platelet aggregation from the saliva of Triatoma pallidipennis.
    Noeske-Jungblut C; Krätzschmar J; Haendler B; Alagon A; Possani L; Verhallen P; Donner P; Schleuning WD
    J Biol Chem; 1994 Feb; 269(7):5050-3. PubMed ID: 8106481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased platelet aggregation due to chilling to 20 degrees C is not related to increased sensitivity to agonists.
    Hansen TN; Brockbank KG
    Transfusion; 1997 Jul; 37(7):696-702. PubMed ID: 9225932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Different effects of endothelin-3 on the Ca2+ discharge induced by agonists and Ca(2+)-ATPase inhibitors in human platelets.
    Astarie-Dequeker C; Korichneva I; Devynck MA
    Br J Pharmacol; 1995 Jan; 114(2):524-30. PubMed ID: 7881751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A possible role for extracellular bicarbonate in U-46619-induced rat platelet aggregation.
    Yokoyama K; Kudo I; Nakamura H; Inoue K
    Thromb Res; 1994 May; 74(4):369-76. PubMed ID: 8085238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the effects of agonists and antagonists on platelet shape change and platelet aggregation in whole blood.
    Sanderson HM; Heptinstall S; Vickers J; Lösche W
    Blood Coagul Fibrinolysis; 1996 Mar; 7(2):245-8. PubMed ID: 8735830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of analogues of adenine nucleotides on increases in intracellular calcium mediated by P2T-purinoceptors on human blood platelets.
    Hall DA; Hourani SM
    Br J Pharmacol; 1993 Mar; 108(3):728-33. PubMed ID: 8467360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role for p38 mitogen-activated protein kinase in platelet aggregation caused by collagen or a thromboxane analogue.
    Saklatvala J; Rawlinson L; Waller RJ; Sarsfield S; Lee JC; Morton LF; Barnes MJ; Farndale RW
    J Biol Chem; 1996 Mar; 271(12):6586-9. PubMed ID: 8636072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local amplification of platelet function by 8-Epi prostaglandin F2alpha is not mediated by thromboxane receptor isoforms.
    Praticò D; Smyth EM; Violi F; FitzGerald GA
    J Biol Chem; 1996 Jun; 271(25):14916-24. PubMed ID: 8663015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.